2024. Transcription factor ASCL1 targets SLC6A13 to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling. Biomolecules and Biomedicine. 24, 6 (Oct. 2024), 1606–1619. DOI:https://doi.org/10.17305/bb.2024.10328.